Pune, India -- (SBWIRE) -- 01/22/2020 -- Global Sjögren's syndrome market is rising gradually with a steady CAGR of 4% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. Increasing incidence of Sjogren's syndrome and presence of a strong pipeline for the disease is contributing towards this market growth in the upcoming years.

Get Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sjgrens-syndrome-market

Few of the major competitors currently working in the global Sjögren's syndrome market are Advanz Pharmaceutical, Eisai Co., Ltd.,., Novartis AG, AstraZeneca, Genentech, Inc., Nicox, ALLERGAN, Biogen, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Amgen Inc., Lupin, Kissei Pharmaceutical Co., Ltd., Pfizer Inc., Santen Pharmaceutical Co., Ltd., Bausch Health, Resolve Therapeutics, Wize Pharma Inc. among others.

Market Definition:

Sjögren's syndrome is an autoimmune disease that causes dryness of the mouth and eyes. This syndrome is associated with other immune system disorders such as rheumatoid arthritis and lupus. The major symptoms of this syndrome are dryness in eyes and mouth followed by joint pain, swollen salivary glands and others. There are two types of Sjogren's syndromes i.e. primary Sjogren's syndrome and secondary Sjogren's syndrome.
The prevalence rate of Sjogren's syndrome is estimated to be 0.1 to 4% of global population. The occurrence of this disease in women is 10 times higher than men. Sjogren's syndrome can occur in any age group, but it is most common in age of 45 to 55 years.

Market Drivers

- Increasing incidence of Sjogren's syndrome and other autoimmune diseases are major drivers for the growth of market

- Rise in geriatric population susceptible to autoimmune diseases will drive the market growth

- Improvement in health care expenditure in many countries for the disease treatmnet will also boost the market growth in the forecast period

- Strong drug pipeline present for the disease is another factor driving the market growth

Market Restraints

- Unwanted immunogenicity caused by drugs used for treatment of Sjogren's syndrome hampers the market growth

- Lack of awareness about sjogren's syndrome acts as restrain to the market growth

- Lack of proper treatment of Sjogren's syndrome is another factor which hinders the market growth

Avail Discount On this Report @ https://www.databridgemarketresearch.com/request-a-discount/global-sjgrens-syndrome-market

Segmentation: Global Sjögren's Syndrome Market

By Type

- Primary Sjögren's Syndrome
- Secondary Sjögren's Syndrome

By Symptoms

- Dry Eyes
- Dry Mouth
- Others

By Diagnosis

- Blood Tests
- Eye Tests
- Lip Biopsy
- Others

By Treatment

- Medication
- Surgery
- Others

By Drugs

- Salagen
- Evoxac
- Plaquenil
- Others

By End Users

- Hospitals
- Homecare
- Specialty Clinics
- Others

By Distribution Channels

- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Others

By Geography

- North America
o U.S.
o Canada
o Mexico
- Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Turkey
o Russia
o Hungary
o Lithuania
o Austria
o Ireland
o Norway
o Poland
o Rest of Europe
- Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Singapore
o Malaysia
o Thailand
o Indonesia
o Philippines
o Vietnam
o Rest of Asia-Pacific
- South America
o Brazil
o Argentina
o Peru
o Rest of South America
- Middle East and Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait
o Israel
o Egypt
o Rest of Middle East and Africa

Key Developments in the Market:

- In May 2019, IntelGenx Corp. received the U. S. patent from the United States Patent and Trademark Office for design and manufacturing of topical oral films (TOF) for treatment of Sjögren's syndrome and other conditions such as gingivitis, buccal ulcers and canker sores. This patent is entitled as "Film Dosage Form with Extended Release Mucoadhesive Particles." This patent issue provides intellectual property rights to the company for manufacturing and marketing exclusivity of topical oral films (TOF)

- In April 2019, Advanz Pharmaceutical acquired the global marketing rights of Salagen (pilocarpine hydrochloride) from Eisai Co., Ltd. Salagen is used for treatment of dry mouth in patients suffering from Sjögren's syndrome. In this acquisition Advanz Pharmaceutical has received the marketing and commercialization approval of salagen worldwide except Japan

Competitive Analysis:

Global Sjögren's syndrome market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Sjögren's syndrome market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

- Current and future of global Sjögren's syndrome market outlook in the developed and emerging markets

- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

- Regions/Countries that are expected to witness the fastest growth rates during the forecast period

- The latest developments, market shares, and strategies that are employed by the major market players

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-sjgrens-syndrome-market

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com